AHA, others urge Supreme Court to bar excessive FCA penalties

The AHA, Pharmaceutical Research and Manufacturers of America, and U.S. Chamber of Commerce today urged the U.S. Supreme Court to bar civil monetary penalties under the False Claims Act that irrationally exceed the harm actually suffered by the government.

Related Resources

Letter/Comment
Public
AHA comments on the Centers for Medicare & Medicaid Services’ fiscal year 2020 proposed rule for the IRF prospective payment system.
Letter/Comment
Public
AHA comments on Medicare for All to House Ways and Means Committee.
Public
An analysis by Monica Noether and Ben Stearns of Charles River Associates of  White, Chapin and Christopher Whaley, “Prices Paid to Hospitals by Private Health…
Letter/Comment
Public
AHA recommends CMS actions to reduce burden of clinical documentation.
Press Releases
Testimony
Public
AHA Statement before the House Committee on Budget on Key Design Components and Considerations for Establishing a Single-Payer Health Care System